BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31585268)

  • 1. Identification of lipid-like salicylic acid-based derivatives as potent and membrane-permeable PTP1B inhibitors.
    Li L; Tavallaie MS; Xie F; Xia Y; Liang Y; Jiang F; Fu L
    Bioorg Chem; 2019 Dec; 93():103296. PubMed ID: 31585268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Y-shaped bis-arylethenesulfonic acid esters: Potential potent and membrane permeable protein tyrosine phosphatase 1B inhibitors.
    Yang F; Xie F; Zhang Y; Xia Y; Liu W; Jiang F; Lam C; Qiao Y; Xie D; Li J; Fu L
    Bioorg Med Chem Lett; 2017 May; 27(10):2166-2170. PubMed ID: 28372909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 2-ethoxy-4-(methoxymethyl)benzamide derivatives as potent and selective PTP1B inhibitors.
    Xie F; Liang Y; Xia Y; Luo S; Jiang F; Fu L
    Bioorg Chem; 2019 Nov; 92():103273. PubMed ID: 31539748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 1,3-diphenyl-1H-pyrazole derivatives containing rhodanine-3-alkanoic acid groups as potential PTP1B inhibitors.
    Sun L; Wang P; Xu L; Gao L; Li J; Piao H
    Bioorg Med Chem Lett; 2019 May; 29(10):1187-1193. PubMed ID: 30910462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Quinolone-3-carboxylic acids as cell-permeable inhibitors of protein tyrosine phosphatase 1B.
    Zhi Y; Gao LX; Jin Y; Tang CL; Li JY; Li J; Long YQ
    Bioorg Med Chem; 2014 Jul; 22(14):3670-83. PubMed ID: 24906513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
    Liu P; Du Y; Song L; Shen J; Li Q
    Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the inhibitory activity of natural tanshinones from Salvia miltiorrhiza roots on protein tyrosine phosphatase 1B.
    Kim DH; Paudel P; Yu T; Ngo TM; Kim JA; Jung HA; Yokozawa T; Choi JS
    Chem Biol Interact; 2017 Dec; 278():65-73. PubMed ID: 29031618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and evaluation of the hybrid of bromophenol and saccharide as potent and selective protein tyrosine phosphatase 1B inhibitors.
    Zhang R; Yu R; Xu Q; Li X; Luo J; Jiang B; Wang L; Guo S; Wu N; Shi D
    Eur J Med Chem; 2017 Jul; 134():24-33. PubMed ID: 28395151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel N-aryl-ω-(benzoazol-2-yl)-sulfanylalkanamides as dual inhibitors of α-glucosidase and protein tyrosine phosphatase 1B.
    Wang MY; Cheng XC; Chen XB; Li Y; Zang LL; Duan YQ; Chen MZ; Yu P; Sun H; Wang RL
    Chem Biol Drug Des; 2018 Sep; 92(3):1647-1656. PubMed ID: 29745030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design, synthesis, and structure-activity relationships of 5-amino-1H-pyrazole-4-carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.
    Basu S; Prathipati P; Thorat S; Ansari S; Patel M; Jain V; Jinugu RR; Niranjan S; De S; Reddy S
    Bioorg Med Chem; 2017 Jan; 25(1):67-74. PubMed ID: 28340988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
    Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
    Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of protein tyrosine phosphatase1B inhibitors defined by binding sites in crystalline complexes.
    Zhang Y; Du Y
    Future Med Chem; 2018 Oct; 10(19):2345-2367. PubMed ID: 30273014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
    He HB; Gao LX; Deng QF; Ma WP; Tang CL; Qiu WW; Tang J; Li JY; Li J; Yang F
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7237-42. PubMed ID: 23067554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Design, synthesis and evaluation of malonic acid-based PTP1B inhibitors].
    Du X; Zhang SE; Liu JZ; Nie FL; Ye F; Tian JY; Xiao ZY
    Yao Xue Xue Bao; 2012 Mar; 47(3):367-73. PubMed ID: 22645761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent protein tyrosine phosphatase 1B (PTP1B) inhibiting constituents from Anoectochilus chapaensis and molecular docking studies.
    Cai J; Zhao L; Tao W
    Pharm Biol; 2015 Jul; 53(7):1030-4. PubMed ID: 25609152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel, potent, selective and cellular active ADC type PTP1B inhibitors via fragment-docking-oriented de novel design.
    Du Y; Ling H; Zhang M; Shen J; Li Q
    Bioorg Med Chem; 2015 Aug; 23(15):4891-4898. PubMed ID: 26100442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diphenylether derivative as selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) over t-cell protein tyrosine phosphatase (TCPTP) identified through virtual screening.
    Reddy MV; Ghadiyaram C; Panigrahi SK; Hosahalli S; Mangamoori LN
    Mini Rev Med Chem; 2013 Oct; 13(11):1602-6. PubMed ID: 24000798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzo[c][1,2,5]thiadiazole derivatives: A new class of potent Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors.
    Wang WL; Chen XY; Gao Y; Gao LX; Sheng L; Zhu J; Xu L; Ding ZZ; Zhang C; Li JY; Li J; Zhou YB
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5154-5157. PubMed ID: 29100798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, SAR and docking studies of substituted aryl phenylthiazolyl phenylcarboxamide as potential protein tyrosine phosphatase 1B (PTP1B) inhibitors.
    Varshney K; Gupta AK; Rawat A; Srivastava R; Mishra A; Saxena M; Srivastava AK; Jain S; Saxena AK
    Chem Biol Drug Des; 2019 Jul; 94(1):1378-1389. PubMed ID: 30903642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
    Morishita K; Shoji Y; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
    Chem Pharm Bull (Tokyo); 2018; 66(12):1131-1152. PubMed ID: 30504630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.